Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
9
×
life sciences
national blog main
san francisco blog main
9
×
boston top stories
san diego blog main
san francisco top stories
biotech
national top stories
new york blog main
san diego top stories
clinical trials
fda
indiana blog main
new york top stories
raleigh-durham blog main
seattle blog main
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana top stories
national
raleigh-durham top stories
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
medicare
novartis
alnylam pharmaceuticals
amgen
boston
cancer
gene therapy
investing
merck
What
patients
9
×
drug
bio
roundup
fda
therapy
developers
gene
healthcare
help
market
medicine
million
moves
startup
acquisitions
advantages
ago
albert
alnylam
analytics
approve
aren’t
awaits
bar
becker
beta
biggest
billions
biofourmis
biological
bionics
blood
bourla
brings
cancer
ceo
closed
company
crispr
Language
unset
unknown
Current search:
patients
×
" san francisco blog main "
×
" boston blog main "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets